US Broker Ratings

BioNTech SE (BNTX) Stock Analysis: Unpacking a 33% Potential Upside Amid Challenging Metrics

BioNTech SE (NASDAQ: BNTX) has been a focal point in the biotechnology sector, especially following its pivotal role in developing a successful mRNA vaccine for COVID-19. As the world transitions..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: A Biotech Leader with a 70.90% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a biotechnology stalwart in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the innovative world of RNA-targeted medicines. With a market..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 20.20% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY) stands out in the healthcare sector as a dynamic player offering technology-enabled services platforms to consumers and employers across the United States. As the company continues..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Closer Look at Its Financial Trajectory and Market Position

Bio-Rad Laboratories, Inc. (NYSE: BIO) has long been a stalwart in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $8.15 billion, Bio-Rad has established..

Vertex Pharmaceuticals (VRTX) Stock Analysis: A Healthcare Giant with 14% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a formidable player in the biotechnology sector, with a market capitalization of $123.26 billion. The company’s commitment to transforming the lives of patients..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Exploring a 6.63% Potential Upside Amid Strong Revenue Growth

As an integral player in the healthcare sector, West Pharmaceutical Services, Inc. (NYSE: WST) stands out in the medical instruments and supplies industry. With a robust market capitalization of $25.31..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 5.74% Upside Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) stands at the forefront of the biotechnology industry with a strategic focus on developing and commercializing pharmaceutical products across the globe. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Exploring a 9.72% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, stands at an intriguing juncture for investors eyeing the medical instruments and supplies industry. With a market capitalization of..

Bio-Techne Corp (TECH) Stock Analysis: Evaluating the Investment Potential in a Stagnant Market

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, is a company that commands attention, especially for those keeping an eye on the healthcare industry. With a market..

Natera, Inc. (NTRA) Investor Outlook: Strong Buy Ratings and Robust Revenue Growth

Natera, Inc. (NASDAQ: NTRA), a prominent player in the healthcare sector specializing in diagnostics and research, has captured significant investor interest, thanks to a combination of robust revenue growth and..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 23.41% Potential Upside with Robust Dividend Yield

As an investor in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing opportunity with its extensive portfolio in medical devices. Headquartered in Amsterdam, Netherlands, Philips operates globally,..

Masimo Corporation (MASI) Stock Analysis: A Steady Performer with a Strong ROE and Consistent Growth

Masimo Corporation (NASDAQ: MASI), a prominent player in the healthcare sector, specializes in medical devices with a focus on patient monitoring technologies. Headquartered in Irvine, California, Masimo has carved out..

Viatris Inc. (VTRS) Stock Analysis: Navigating Growth in the Healthcare Sector with a 3% Upside Potential

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is making waves among investors with its strategic positioning in the drug manufacturing industry, particularly in specialty and generic..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a 15.68% Potential Upside for Investors

For investors with an eye on the biotechnology sector, Ascendis Pharma A/S (NASDAQ: ASND) presents a compelling opportunity, boasting a potential upside of 15.68% according to recent analyst ratings. With..

Repligen Corporation (RGEN) Investor Outlook: A 20.92% Potential Upside Beckons Amid Robust Revenue Growth

Repligen Corporation (NASDAQ: RGEN), a significant player in the healthcare sector specializing in medical instruments and supplies, offers a compelling prospect for investors drawn by its potential upside and solid..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 25% Upside Potential for Investors

ResMed Inc. (NYSE: RMD), a key player in the healthcare sector, continues to capture investor attention with its robust portfolio of medical instruments and cloud-based software solutions targeting respiratory disorders...

Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings

Investors eyeing opportunities in the healthcare sector might find Alcon Inc. (NYSE: ALC) an intriguing candidate, particularly with its promising 24.66% potential upside based on analysts’ average target price. As..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a Potential 108.75% Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT), a biopharmaceutical company with a focus on developing groundbreaking therapies, is making waves in the biotechnology sector. With a market capitalization of $10.72 billion, Summit..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Booming Biotech with a 42.2% Revenue Growth

Investors looking for a compelling opportunity in the biotechnology sector might find Halozyme Therapeutics, Inc. (NASDAQ: HALO) an intriguing prospect. With a market capitalization of $9.23 billion, this San Diego-based..

Humana Inc. (HUM) Stock Analysis: Evaluating the Healthcare Giant’s Market Position and Performance Metrics

For investors keen on the healthcare sector, Humana Inc. (NYSE: HUM) presents an intriguing opportunity, given its robust market position and impressive revenue growth figures. As a leading player in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds